Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radiation biology, immunologic, and hemorheologic effects of a prostaglandin-leukotriene inhibitor

Thesis/Dissertation ·
OSTI ID:5336565
This work examined the effects of a prostaglandin-leukotriene inhibitor (Meclomen) on the radiation-induced proctitis and brain edema in primates, and on the total-body-irradiated Balb/c mice. This work also investigated the radioprotective effect on Meclomen on the radiation-induced mucositis in patients with malignancies. In preliminary animal toxicologic experiments we found that Meclomen at a dose of 20 mg/kg is safe when administered to monkeys and mice. We also found that the most frequent toxic signs, in mice receiving toxic doses, were hypoactivity, irritability, convulsions, and death. We observed that Meclomen minimized the death rate, prolonged the life expectancy, and prevented the microscopic liver changes of Balb/C mice that received total body irradiation. However, the drug had no effect on the LD50/15 of the irradiated mice. Meclomen proved to be a radioprotector against radiation-induced proctitis and brain edema in primates.
Research Organization:
State Univ. of New York, Buffalo (USA)
OSTI ID:
5336565
Country of Publication:
United States
Language:
English